Funder
NIDDK
American Society of Nephrology
Reference32 articles.
1. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2.4 million patients from 11 countries: the CaReMe CKD study;Sundstrom;Lancet Reg Health Eur,2022
2. Tubular biomarkers and chronic kidney disease progression in Sprint participants;Jotwani;Am J Nephrol,2020
3. Biomarkers of kidney tubule health, CKD progression, and acute kidney injury in Sprint (systolic blood pressure intervention trial) participants;Bullen;Am J Kidney Dis,2021
4. Biomarkers of kidney tubule disease and risk of end-stage kidney disease in persons with diabetes and CKD;Amatruda;Kidney Int Rep,2022
5. Distinct dimensions of kidney health and risk of cardiovascular disease, heart failure, and mortality;Lee;Hypertension,2019